The RNAi race: Tekmira signs $50 million deal with Roche while Calando watches
May 19, 2009 | Analyst Insight
With the recent flurry of funding and failing of emerging technology companies in the pharmaceutical arena, start-ups everywhere are fearing upcoming judgment days, requiring them to either establish partnerships or close...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.